Mamedica Data Reveals 66% of Brits Report Cannabis Use
Mamedica cannabis use UK data reveals that 66% of British adults report cannabis use, suggesting significant underreporting in clinical settings. This prevalence has important implications for patient disclosure and clinical assessment in UK healthcare.…
Long-term cannabis use changes brain structure and leaves users unable to make decisions – MSN
Long-term cannabis use cognitive effects include changes in brain structure and potential impacts on decision-making. Neuroimaging studies reveal alterations in prefrontal regions linked to executive function. Understanding these cognitive effects is…
Meningitis kills a quarter million people a year – study
The meningitis mortality global study reveals approximately 250,000 deaths annually worldwide. This high clinical relevance highlights the urgent need for preventive strategies and rapid treatment protocols. Understanding meningitis neurological risks is…
Why People Use Cannabis Predicts Whether Use Becomes Harmful, Review Finds
A 2024 narrative review highlights that cannabis use motives, particularly coping motives, strongly predict cannabis-related problems and disorder. Medical and coping motives overlap, complicating clinical assessment. Understanding cannabis use motives…
Substance Use and Suicide Attempts in Adolescents: Clinical and Psychosocial Factors
Adolescent substance use and suicide risk represent critical intersecting clinical challenges. This study analyzes clinical and psychosocial risk factors linked to suicide attempts in adolescents with substance use disorders. Understanding these risk…
People with Cannabis Disorder Show Unique Neurobiology and Attention Patterns
Cannabis use disorder neurobiology reveals distinct brain pathways compared to other addictions. Individuals with this disorder do not show increased attention to cannabis-related images. This suggests unique cognitive mechanisms in cannabis use disorder.